About RMLS

GMP Production for
Regenerative Biologics

RMLS Labs produces stem cells, exosomes, MUSE cells, and custom biologic preparations through controlled workflows designed for consistency, traceability, product integrity, and documented lot release.

GMP
Oriented Workflows
3D
Culture Systems
QC
Release Testing
CoA
Lot Documentation
GMP Production

A Higher Standard
For Biological Integrity

RMLS Labs is focused on the production of high-quality regenerative biologics, including umbilical cord-derived mesenchymal stem cells, MSC-derived exosomes, MUSE cells, and custom biologic programs.

Our work emphasizes controlled production, 3D culture systems, documented lots, and third-party release testing for sterility, mycoplasma, endotoxin, post-thaw viability, and cell surface marker identity. This gives research and translational teams biologics produced through consistent, traceable processes with lot-specific documentation available for review.

View Products CoA Lookup
Production Priorities
Controlled Production
GMP-oriented workflows designed to support consistency, traceability, and reproducible handling from production through release.
3D Culture Systems
Advanced culture systems used to support scalable production of stem cells and exosome preparations.
Third-Party Release Testing
Release testing includes third-party review for sterility, mycoplasma, endotoxin, post-thaw viability, and cell surface marker identity before lot release.
Documented Lots
Every lot is documented, with Certificates of Analysis and supporting records available through code-based lookup where applicable.
Production Workflow

From Source Material to
Documented Release

The RMLS production model is built around clean sourcing, controlled culture conditions, defined manufacturing steps, independent release testing, and documentation that supports lot review and traceability.

01
Sourcing
Umbilical cord-derived starting material from qualified, consented donor sources under controlled conditions.
02
Cell Expansion
Stem cells expanded using controlled workflows designed to preserve biological integrity and reproducibility.
03
3D Culture
Three-dimensional culture systems support scalable production and biologically relevant culture conditions.
04
Exosome Production
MSC-derived exosome preparations produced from controlled parent-cell culture systems.
05
Quality Release
Release testing includes third-party testing for sterility, mycoplasma, endotoxin, post-thaw viability, and cell surface marker identity.
06
Lot Documentation
All lots are documented so researchers can review CoA support, release criteria, and lot-specific technical details.

Explore GMP-produced
regenerative biologics.

View RMLS products, retrieve lot documentation, or contact the lab for product, testing, and production questions.

View Products CoA Lookup Email RMLS